CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hemispherx Biopharma, Inc. Company Snapshot
Hemispherx Biopharma, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hemispherx Biopharma with three other companies in this sector in the United States: Neuralstem, Incorporation. (2018 sales of $260,000.00 ), Trovagene Inc ($378,325.00 of which 100% was Biological Product), and CEL-SCI Corporation ($476,556.00 ).

Sales Analysis. Hemispherx Biopharma reported sales of $367,000.00 for the year ending December of 2018. This represents a decrease of 16.0% versus 2017, when the company's sales were $437,000.00 .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hemispherx Biopharma, Inc.
  Stock Performance Chart for Hemispherx Biopharma, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (8/23/2019): 1.93
(Figures in U.S. Dollars)
1 Week 2.1%   13 Weeks -29.8%  
4 Weeks -66.2%   52 Weeks -83.8%  
 
Hemispherx Biopharma, Inc. Key Data:
  Ticker: HEB Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 367,000
(Year Ending Jan 2019).
Employees: 33
  Currency: U.S. Dollars Market Cap: 4,274,815
  Fiscal Yr Ends: December Shares Outstanding: 2,214,930
  Share Type: Common Closely Held Shares: 170,630
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.